Risk Factors and Outcomes for Isolation with Polymyxin B-Resistant Enterobacterales from 2018–2022: A Case-Control Study

References

• El-Sayed Ahmed MAE, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB. Colistin and its role in the era of antibiotic resistance: an extended review (2000–2019). Emerg Microbes Infect. 2020;9(1):868–885. doi:10.1080/22221751.2020.1754133
   PubMed Web of Science ®Google Scholar
• Stefaniuk EM, Tyski S. Colistin resistance in enterobacterales strains - a current view. Pol J Microbiol. 2019;68(4):417–427. doi:10.33073/pjm-2019-055
   PubMed Web of Science ®Google Scholar
• Srinivas P, Rivard K. Polymyxin resistance in gram-negative pathogens. Curr Infect Dis Rep. 2017;19(11):38. doi:10.1007/s11908-017-0596-3
   PubMed Web of Science ®Google Scholar
• Richter SE, Miller L, Uslan DZ, et al. Risk factors for colistin resistance among gram-negative rods and Klebsiella pneumoniae isolates. J Clin Microbiol. 2018;56(9):e00149–e00218. doi:10.1128/JCM.00149-18
   PubMed Web of Science ®Google Scholar
• Seethalakshmi PS, Rajeev R, Prabhakaran A, Kiran GS, Selvin J. The menace of colistin resistance across globe: obstacles and opportunities in curbing its spread. Microbiol Res. 2023;270:127316. doi:10.1016/j.micres.2023.127316
   PubMedGoogle Scholar
• Nang SC, Li J, Velkov T. The rise and spread of mcr plasmid-mediated polymyxin resistance. Crit Rev Microbiol. 2019;45(2):131–161. doi:10.1080/1040841X.2018.1492902
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhu Y, Lin YW, et al. Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2022;28(7):1026.e1–1026.e5. doi:10.1016/j.cmi.2022.02.043
   Web of Science ®Google Scholar
• Yang TY, Wang SF, Lin JE, et al. Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents. 2020;55(3):105894. doi:10.1016/j.ijantimicag.2020.105894
   PubMed Web of Science ®Google Scholar
• Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31(4):707–721. doi:10.1185/03007995.2015.1018989
   PubMed Web of Science ®Google Scholar
• Moffatt JH, Harper M, Boyce JD. Mechanisms of polymyxin resistance. Adv Exp Med Biol. 2019;1145:55–71. doi:10.1007/978-3-030-16373-0_5
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang H, Liu YH, Feng Y. Towards understanding MCR-like colistin resistance. Trends Microbiol. 2018;26(9):794–808. doi:10.1016/j.tim.2018.02.006
   PubMed Web of Science ®Google Scholar
• Ling Z, Yin W, Shen Z, Wang Y, Shen J, Walsh TR. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother. 2020;75(11):3087–3095. doi:10.1093/jac/dkaa205
   PubMed Web of Science ®Google Scholar
• Rhouma M, Madec JY, Laxminarayan R. Colistin: from the shadows to a one health approach for addressing antimicrobial resistance. Int J Antimicrob Agents. 2023;61(2):106713. doi:10.1016/j.ijantimicag.2023.106713
   PubMed Web of Science ®Google Scholar
• Lu J, Han M, Yu HH, et al. Lipid A modification and metabolic adaptation in polymyxin-resistant, New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae. Microbiol Spectr. 2023;11(4):e0085223. doi:10.1128/spectrum.00852-23
   PubMed Web of Science ®Google Scholar
• Teo JQ, Chang CW, Leck H, et al. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: a case-control study. Int J Antimicrob Agents. 2019;53(5):657–662. doi:10.1016/j.ijantimicag.2019.03.011
   PubMed Web of Science ®Google Scholar
• da Silva KE, Baker S, Croda J, et al. Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: an epidemiological and clinical study. Int J Antimicrob Agents. 2020;55(3):105882. doi:10.1016/j.ijantimicag.2020.105882
   PubMed Web of Science ®Google Scholar
• Büchler AC, Gehringer C, Widmer AF, Egli A, Tschudin-Sutter S. Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study. Euro Surveill. 2018;23(30):1700777. doi:10.2807/1560-7917.ES.2018.23.30.1700777
   PubMedGoogle Scholar
• Kazlauskas E, Gegieckaite G, Eimontas J, Zelviene P, Maercker A. A brief measure of the international classification of diseases-11 adjustment disorder: investigation of psychometric properties in an adult help-seeking sample. Psychopathology. 2018;51(1):10–15. doi:10.1159/000484415
   PubMed Web of Science ®Google Scholar
• European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version. 2023;13(1):1.
   Google Scholar
• Giamarellou H. Epidemiology of infections caused by polymyxin-resistant pathogens. Int J Antimicrob Agents. 2016;48(6):614–621. doi:10.1016/j.ijantimicag.2016.09.025
   PubMed Web of Science ®Google Scholar
• Arjun R, Gopalakrishnan R, Nambi PS, Kumar DS, Madhumitha R, Ramasubramanian V. A study of 24 patients with colistin-resistant gram-negative isolates in a tertiary care hospital in South India. Indian J Crit Care Med. 2017;21(5):317–321. doi:10.4103/ijccm.IJCCM_454_16
   PubMedGoogle Scholar
• de Maio Carrillho CM, Gaudereto JJ, Martins RC, et al. Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy. Diagn Microbiol Infect Dis. 2017;87(3):253–257. doi:10.1016/j.diagmicrobio.2016.11.007
   PubMed Web of Science ®Google Scholar
• Balkhair A, Saadi KA, Adawi BA. Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections. IJID Reg. 2023;7:1–5. doi:10.1016/j.ijregi.2023.01.002
   PubMedGoogle Scholar
• Huang PH, Cheng YH, Chen WY, et al. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(6):106342. doi:10.1016/j.ijantimicag.2021.106342
   PubMed Web of Science ®Google Scholar
• Gundogdu A, Ulu-Kilic A, Kilic H, et al. Could frequent carbapenem use be a risk factor for colistin resistance? Microb Drug Resist. 2018;24(6):774–781. doi:10.1089/mdr.2016.0321
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Del Bono V, Trecarichi EM, et al. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study. Clin Microbiol Infect. 2015;21(12):1106.e1–1106.e11068. doi:10.1016/j.cmi.2015.08.001
   Web of Science ®Google Scholar
• Zhang HL, Han JH, Lapp Z, et al. Risk factors for colistin-resistant carbapenem-resistant Klebsiella pneumoniae in the postacute care setting. Open Forum Infect Dis. 2022;9(9):ofac452. doi:10.1093/ofid/ofac452
   PubMed Web of Science ®Google Scholar
• Xu X, Zhu R, Lian S, et al. Risk factors and molecular mechanism of polymyxin B resistance in carbapenem-resistant Klebsiella pneumoniae isolates from a tertiary hospital in Fujian, China. Infect Drug Resist. 2022;15:7485–7494. doi:10.2147/IDR.S391674
   PubMed Web of Science ®Google Scholar
• Wang Y, Tian GB, Zhang R, et al. Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. Lancet Infect Dis. 2017;17(4):390–399. doi:10.1016/S1473-3099(16)30527-8
   PubMed Web of Science ®Google Scholar
• Mills JP, Rojas LJ, Marshall SH, et al. Risk factors for and mechanisms of COlistin resistance among Enterobacterales: getting at the CORE of the issue. Open Forum Infect Dis. 2021;8(7):ofab145. doi:10.1093/ofid/ofab145
   PubMed Web of Science ®Google Scholar
• Papadimitriou-Olivgeris M, Bartzavali C, Spyropoulou A, et al. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period. Diagn Microbiol Infect Dis. 2018;92(3):235–240. doi:10.1016/j.diagmicrobio.2018.06.001
   PubMed Web of Science ®Google Scholar
• Balkan II, Alkan M, Aygün G, et al. Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae. Eur J Clin Microbiol Infect Dis. 2021;40(10):2161–2170. doi:10.1007/s10096-020-04124-y
   PubMed Web of Science ®Google Scholar